Why Pfizer’s Trump deal is good news for all of big pharma

Wall Street Journal

2 October 2025 - The company’s accord with the president clears a cloud over the whole sector.

Big Pharma has been out of favour with investors on fears of tariffs and price controls. This week might have marked a turning point.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder